Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: An intergroup rhabdomyosarcoma study

Genes Chromosomes and Cancer

Volumn 27, Issue 4, 2000, Pages 337-344

  Bridge, Julia A ^a   Liu, Jian ^a   Weibolt, Vines ^a,b   Baker, K Scott ^c   Perry, Deborah ^d   Kruger, Robert ^c   Qualman, Stephen ^e   Barr, Frederic ^f   Sorensen, Poul ^g   Triche, Timothy ^h   Suijkerbuijk, Ron ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e NATIONWIDE CHILDREN S HOSPITAL   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g BC CHILDREN S HOSPITAL   (Canada)

^h CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADOLESCENT; ARTICLE; CHILD; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; EMBRYONAL RHABDOMYOSARCOMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ADOLESCENT; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; MALE; NUCLEIC ACID HYBRIDIZATION; PROSTATIC NEOPLASMS; RHABDOMYOSARCOMA, EMBRYONAL; URINARY BLADDER NEOPLASMS; UTERINE NEOPLASMS;

EID: 0034088133     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(200004)27:4<337::AID-GCC1>3.0.CO;2-1     Document Type: Article

References (29)

1. Barr FG. 1997. Molecular genetics and pathogenesis of rhabdomyosarcoma. J Fed Hem Oncol 19:483-191.
2. Blair IP, Hulme D, Dawkins JL, Nicholson GA. 1998. A YAC-based transcript map of human chromosome 9q22.1-q22.3 encompassing the loci for hereditary' sensory neuropathy type I and multiple self-healing squamous epithelioma. Genomics 51:277-281.
3. Bridge JA. 1997. Soft tissue sarcomas. In: Wolman SR, Sell S, editors. Cytogenetic markers of human disease. Clifton, New Jersey: Humana Press, p 425-459.
4. Bridge JA, Fidler ME, Neff JR, Degenhardt J, Wang M, Walker C, Dorfman HD, Baker KS, Seemayer TA. 1999. Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift. Am J Surg Pathol 23:159-165.
5. Davis RJ, D'Cruz, CM, Lovell MA, Biegel JA, Barr FG. 1994. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 54:2869-2972.
6. DeSouza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL. 1995. M6P/IGFIR gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nature Genet 11:447-449.
7. Downing JR, Khandekar A, Shurtleff SA, Head DR, Parham DM, Webber BL, Pappo AS, Hulshof MD, Conn WP, Shapiro DN. 1995. Multiplex RT-PCR assay for the differential diagnosis of alveolar rhabdomyosarcoma and Ewing's sarcoma. Am J Pathol 146:626-634.
8. Enzinger FM, Weiss SW. 1995. Soft tissue tumors. 3rd ed. St. Louis: Mosby-Year Book, Inc.
9. Farndon PA, Del Mastro RG, Evans DGR, Kilpatrick MW. 1992. Location of gene for Gorlin syndrome. Lancet 339:581-582.
10. Forus A, Florenes V, Maclandsmo G, Meltzer P, Fodstad O, Myklebost O. 1993. Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2. Cell Growth Differ 4:1065-1070.
11. Gailani MR, Ståhle-Bäckdahl M, Leffell DJ, Glynn M, Zaphiropoulos PG, Pressman C, Undén AB, Dean M, Brash DE, Bale AE, Toftgård R. 1996. The role of the human homologue for Drosophila patrched in sporadic basal cell carcinomas. Nature Genet 13:78-81.
12. Hahn H, Wojnowski L, Zimmer AM, Hall J, Miller G, Zimmer A. 1998. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nature Med 4:619-622.
13. Iolascon A, Lo-Cunsolo C, Giordani L, Cusano R, Mazzocco K, Boumgartner M, Ghiselini P, Faienza MF, Boni L, De-Bernardi B, Conte M, Romeo G, Tonini GP. 1998. Interstitial and large chromosome 1p deletion occurs in localized and disseminated neuroblastomas and predicts an unfavourable outcome. Cancer Lett 130:83-92.
14. Kallioniemi O-P, Kallioniemi A. Piper J, Isola J, Waldman FM, Gray JW, Pinkel D. 1994. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10:231-243.
15. Komuro H, Valentine MB, Rowe ST, Kidd VJ, Makono S, Brodeur GM, Cohn SL, Look AT. 1998. Fluorescence in situ hybridization analysis of chromosome 1p36 deletion in human MYCN amplified neuroblastoma. J Pediatr Surg 33:1695-1698.
16. Lawrence W, Anderson JR, Gehan EA, Maurer H. 1997. Pretreatment TNM staging of childhood rhabdomyosarcoma. A report of the Intergroup Rhabdomyosarcoma Study Group. Cancer 80:1165-1170.
17. Mandahl N, Akerman M, Aman P, Dal Cin P, De Wever I, Fletcher CD, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, Van den Berghe II, Van de Ven W, Vanni R, Willen H. 1996. Duplication of chromosome segment 12q 15-24 is associated with atypical lipomatous tumors: a report of the CHAMP collaborative study group. Int J Cancer 67:632-635.
18. Polito P, Dal Cin P, Sciot R, Brock P, Van Eyken P, Van den Berghe H. 1999. Embryonal rhabdomyosarcoma with only numerical chromosome changes. Case report and review of the literature. Cancer Genet Cytogenet 109:161-165.
19. Sandberg AA, Bridge JA. 1994. The cytogenetics of bone and soft tissue tumors. Austin, TX: R.G. Landes.
20. Schleiermacher G, Delattre O Peter M, Mosseri V, Delonlay P, Vielh P, Thomas G, Zucker JM, Maqdelenat H, Michon J. 1996. Clinical relevance of loss of heterozygosity of the short arm of chromosome 1 in neuroblastoma: a single institution study. Int J Cancer 69:73-78.
21. Schmidt L, Duh F-M, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky I, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis JT, Casadevall C, Zamarron A, Bernue M, Richard S, Lips CJM, Walther MM, Tsui L-C, Geil L, Orcutt ML, Stackhouse T, Lipan J, Slife L, Brauch H, Decker J, Niehans G, Hughson MD, Moeh H, Storkel S, Lerman MI, Linehan WM, Zbar B. 1997. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nature Genet 16:68-73.
22. Scrable H, Cavenee W, Ghavimi F, Lovell M, Morgan L. 1989a. A model for embryonal rhabdomyosarcoma tumorigenesis that involves genomic imprinting. Proc Natl Acad Sci USA 86:7480-7484.
23. Scrable H, Witte D, Shimada H, Seemayer TA, Wang Wuu S, Soukup S, Koufos A, Houghton P, Lampkin B, Cavenee W. 1989b. Molecular differential pathology of rhabdomyosarcoma. Genes Chromosomes Cancer 1:23-35.
24. Steilen-Gimbel H, Remberger K, Graf N, Steudel W-I., Dieter Zang K, Henn W. 1996. A novel site of DNA amplification on chromosome 1p32-33 in a rhabdomyosarcoma revealed by comparative genomic hybridization. Hum Genet 97:87-90.
25. Suijkerbuijk RF, van de Veen AY, van Echten J, Buys CHCM, de Jong B, Öosterhuis JW, Warburton DA, Cassiman JJ, Schonk D, Geurts van Kessel A. 1991. Demonstration of the genuine iso(12p) character of the standard marker chromosome of testicular germ cell tumors and identification of further chromosome 12 aberrations by comparative genomic hybridization. Am I Hum Genet 48:269-273.
26. Weber-Hall S, Anderson J, McManus A, Abe S, Nojima T, Pinkerton R, Pritchard-Jones K, Shipley J. 1996. Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization. Cancer Res 56:3220-3224.
27. White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M, Kaufman BA, Biegel JA, Allen C, Hilliard C, Valentine MB, Look AT, Enomoto H, Sakiyama S, Brodeur GM. 1995. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci USA 92:5520-5524.
28. Zhan S, Helman LJ. 1998. Glimpsing the cause of rhabdomyosarcoma. Nature Med 4:559-560.
29. Zhan S, Shapiro N, Helman LJ. 1994. Activation of an imprinting allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma. J Clin Invest 94:445-448.